RPS3A and hepatocellular carcinoma: Within the framework of HBV pathogenesis, eS1/RPS3a has been discovered to be a molecular chaperone that interacts with the HBV HBx protein, thereby promoting the progression of hepatocellular carcinoma (HCC) [73].